MTI
DGX icon

Merrithew & Thorsten Inc’s Quest Diagnostics DGX Stock Holding History

Merrithew & Thorsten Inc’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$370K Buy
1,748
+8
+0.5% +$1.57K 0.32% 21
2026
Q1 		$341K Buy
1,740
+8
+0.5% +$1.55K 0.32% 21
2025
Q4 		$300K Buy
+1,732
New +$315K 0.32% 21

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Merrithew & Thorsten Inc's DGX Position: Q2 2026 in Review

Merrithew & Thorsten Inc increased its Quest Diagnostics (DGX) stake by 0.46% in Q2 2026, buying an estimated $1.57K and bringing the position to 1,748 shares worth $370K. The position accounts for 0.32% of the portfolio, ranked #21.

Merrithew & Thorsten Inc first reported a position in DGX in Q4 2025 and has held it in 3 quarters since. 1,103 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Merrithew & Thorsten Inc held 1,748 shares of Quest Diagnostics worth $370K as of Q2 2026.
  • Merrithew & Thorsten Inc bought 8 Quest Diagnostics shares in Q2 2026, an estimated $1.57K.
  • Quest Diagnostics made up 0.32% of Merrithew & Thorsten Inc's portfolio in Q2 2026, its #21 holding.
  • Merrithew & Thorsten Inc first reported a position in Quest Diagnostics in Q4 2025 and has held it in 3 quarters since.
  • 1,103 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Merrithew & Thorsten Inc's 13F filing for Q2 2026, filed 31 Jul 2026.